Transition of Care for Justice-Involved Adults with Schizophrenia: A 2-month (1064 mg) Long-acting Treatment Option (Lunch Provided)

Go Back

12:00 pm - 1:30 pm

---

In state prison inmates, the prevalence of diagnosed schizophrenia is estimated to be up to 6.5%, while it is estimated at less than 1% in the US adult population.1,2 Long-acting injectable (LAI) therapies may be an option for treating schizophrenia during incarceration. They have recently been considered for medically appropriate adults with schizophrenia as they transition from incarceration to community care settings.3 This program will review a schizophrenia treatment regimen that provides an option of fully dosing for 2 months of treatment in 1 day.